- Home
- USAU vs LUCD Comparison
USAU vs LUCD Comparison
Compare USAU & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAU
- LUCD
- Stock Information
- Founded
- USAU N/A
- LUCD 2018
- Country
- USAU United States
- LUCD United States
- Employees
- USAU N/A
- LUCD N/A
- Industry
- USAU Precious Metals
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- USAU Basic Materials
- LUCD Health Care
- Exchange
- USAU Nasdaq
- LUCD Nasdaq
- Market Cap
- USAU 59.6M
- LUCD 38.4M
- IPO Year
- USAU N/A
- LUCD 2021
- Fundamental
- Price
- USAU $6.00
- LUCD $0.84
- Analyst Decision
- USAU Strong Buy
- LUCD Strong Buy
- Analyst Count
- USAU 1
- LUCD 4
- Target Price
- USAU $11.00
- LUCD $3.94
- AVG Volume (30 Days)
- USAU 81.1K
- LUCD 187.6K
- Earning Date
- USAU 12-13-2024
- LUCD 11-11-2024
- Dividend Yield
- USAU N/A
- LUCD N/A
- EPS Growth
- USAU N/A
- LUCD N/A
- EPS
- USAU N/A
- LUCD N/A
- Revenue
- USAU N/A
- LUCD $3,800,000.00
- Revenue This Year
- USAU N/A
- LUCD $88.22
- Revenue Next Year
- USAU N/A
- LUCD $239.50
- P/E Ratio
- USAU N/A
- LUCD N/A
- Revenue Growth
- USAU N/A
- LUCD 379.19
- 52 Week Low
- USAU $3.05
- LUCD $0.63
- 52 Week High
- USAU $7.06
- LUCD $1.58
- Technical
- Relative Strength Index (RSI)
- USAU 60.77
- LUCD 56.90
- Support Level
- USAU $5.76
- LUCD $0.77
- Resistance Level
- USAU $6.10
- LUCD $0.85
- Average True Range (ATR)
- USAU 0.19
- LUCD 0.03
- MACD
- USAU 0.02
- LUCD 0.00
- Stochastic Oscillator
- USAU 84.85
- LUCD 82.25
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.